423 related articles for article (PubMed ID: 28971574)
1. Aberrant lipid metabolism in cancer cells - the role of oncolipid-activated signaling.
Ray U; Roy SS
FEBS J; 2018 Feb; 285(3):432-443. PubMed ID: 28971574
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells.
Mukherjee A; Wu J; Barbour S; Fang X
J Biol Chem; 2012 Jul; 287(30):24990-5000. PubMed ID: 22665482
[TBL] [Abstract][Full Text] [Related]
3. Lipid desaturation - the next step in targeting lipogenesis in cancer?
Peck B; Schulze A
FEBS J; 2016 Aug; 283(15):2767-78. PubMed ID: 26881388
[TBL] [Abstract][Full Text] [Related]
4. Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis.
Gotoh M; Fujiwara Y; Yue J; Liu J; Lee S; Fells J; Uchiyama A; Murakami-Murofushi K; Kennel S; Wall J; Patil R; Gupte R; Balazs L; Miller DD; Tigyi GJ
Biochem Soc Trans; 2012 Feb; 40(1):31-6. PubMed ID: 22260662
[TBL] [Abstract][Full Text] [Related]
5. Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.
Tigyi GJ; Yue J; Norman DD; Szabo E; Balogh A; Balazs L; Zhao G; Lee SC
Adv Biol Regul; 2019 Jan; 71():183-193. PubMed ID: 30243984
[TBL] [Abstract][Full Text] [Related]
6. Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
Li HY; Oh YS; Choi JW; Jung JY; Jun HS
Kidney Int; 2017 Jun; 91(6):1362-1373. PubMed ID: 28111010
[TBL] [Abstract][Full Text] [Related]
7. Suppression of adipocyte differentiation and lipid accumulation by stearidonic acid (SDA) in 3T3-L1 cells.
Li Y; Rong Y; Bao L; Nie B; Ren G; Zheng C; Amin R; Arnold RD; Jeganathan RB; Huggins KW
Lipids Health Dis; 2017 Sep; 16(1):181. PubMed ID: 28946872
[TBL] [Abstract][Full Text] [Related]
8. Lipid metabolism reprogramming and its potential targets in cancer.
Cheng C; Geng F; Cheng X; Guo D
Cancer Commun (Lond); 2018 May; 38(1):27. PubMed ID: 29784041
[TBL] [Abstract][Full Text] [Related]
9. Roles of LPA receptor signaling in breast cancer.
Wang J; Sun Y; Qu J; Yan Y; Yang Y; Cai H
Expert Rev Mol Diagn; 2016 Oct; 16(10):1103-1111. PubMed ID: 27644846
[TBL] [Abstract][Full Text] [Related]
10. FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth.
Du X; Wang QR; Chan E; Merchant M; Liu J; French D; Ashkenazi A; Qing J
Cancer Res; 2012 Nov; 72(22):5843-55. PubMed ID: 23019225
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic Acid Signaling in Obesity and Insulin Resistance.
D'Souza K; Paramel GV; Kienesberger PC
Nutrients; 2018 Mar; 10(4):. PubMed ID: 29570618
[TBL] [Abstract][Full Text] [Related]
12. Autotaxin and LPA receptor signaling in cancer.
Houben AJ; Moolenaar WH
Cancer Metastasis Rev; 2011 Dec; 30(3-4):557-65. PubMed ID: 22002750
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid (LPA) receptor-mediated signaling and cellular responses to anticancer drugs and radiation of cancer cells.
Ikeda H; Takai M; Tsujiuchi T
Adv Biol Regul; 2024 May; 92():101029. PubMed ID: 38377635
[TBL] [Abstract][Full Text] [Related]
14. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
Khound R; Taher J; Baker C; Adeli K; Su Q
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
[TBL] [Abstract][Full Text] [Related]
15. Autotaxin⁻Lysophosphatidic Acid Signaling in Alzheimer's Disease.
Ramesh S; Govindarajulu M; Suppiramaniam V; Moore T; Dhanasekaran M
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933579
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of lipids and oxidatively damaged DNA in hepatocytes exposed to particles.
Vesterdal LK; Danielsen PH; Folkmann JK; Jespersen LF; Aguilar-Pelaez K; Roursgaard M; Loft S; Møller P
Toxicol Appl Pharmacol; 2014 Jan; 274(2):350-60. PubMed ID: 24121055
[TBL] [Abstract][Full Text] [Related]
17. Development of lysophosphatidic acid pathway modulators as therapies for fibrosis.
Budd DC; Qian Y
Future Med Chem; 2013 Oct; 5(16):1935-52. PubMed ID: 24175745
[TBL] [Abstract][Full Text] [Related]
18. Exendin-4 Inhibits Hepatic Lipogenesis by Increasing β-Catenin Signaling.
Seo MH; Lee J; Hong SW; Rhee EJ; Park SE; Park CY; Oh KW; Park SW; Lee WY
PLoS One; 2016; 11(12):e0166913. PubMed ID: 27907035
[TBL] [Abstract][Full Text] [Related]
19. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
Tabuchi S
Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
[TBL] [Abstract][Full Text] [Related]
20. Allyl isothiocyanate suppresses the proteolytic activation of sterol regulatory element-binding proteins and de novo fatty acid and cholesterol synthesis.
Miyata S; Inoue J; Shimizu M; Sato R
Biosci Biotechnol Biochem; 2016 May; 80(5):1006-11. PubMed ID: 26822063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
